How to buy ARK Innovation (ARKK) ETF from India

Yes, an Indian resident can buy ARKK — legally, under the RBI's Liberalised Remittance Scheme (LRS). ARKK is ARK Invest's flagship actively-managed ETF, run by Cathie Wood, holding roughly 30-40 names across genomics, fintech, robotics, AI and blockchain. What decides your outcome here is whether you actually want a concentrated, active, high-volatility thematic wrapper at a 0.75% expense ratio.

The 30-second version

• Legal and simple. Buy ARKK via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia).
• Actively managed, not an index. ARKK is not a passive tracker. Cathie Wood's team picks roughly 30-40 names they consider "disruptive innovation" leaders, rebalanced continuously.
• Expensive by ETF standards. Expense ratio is 0.75% per year — about 25x what you pay for VOO. That is the active-management premium.
• Concentrated. Top 10 holdings typically run ~60% of the fund. A handful of names move the entire ETF.
• Volatile. ARKK roughly tripled in 2020, then drew down ~75% peak-to-trough through 2022, with a partial recovery since. Position it as a satellite, not a core.
• Estate-tax trap still applies. Directly-held ARKK is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax with no treaty relief.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	ARKK / NYSE Arca
Issuer	ARK Investment Management (Cathie Wood)
Style	Actively managed, high-conviction thematic
Expense ratio	0.75% per year
Holdings	~30-40 names, top 10 around 60% of fund
Methodology	Active stock-picking around "disruptive innovation" themes
Inception	October 2014
Distribution	Historically negligible — focus on growth names, not yield
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). File your W-8BEN during onboarding — it drops US dividend withholding from a flat 30% to the DTAA rate of 25%, though ARKK rarely distributes anything meaningful. New to this? Start with how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. ARKK trades in the low-to-mid double-digit dollar range per share — a whole share is well within most LRS budgets, or buy a fractional rupee amount.

What's actually inside ARKK

ARKK is actively managed. There is no index. Cathie Wood and her analyst team buy what they call "disruptive innovation" — companies they believe will lead five themes: genomics, fintech, next-gen internet (AI and cloud), autonomous tech and robotics, and blockchain.

Top 10 holdings have historically included names like Tesla, Coinbase, Roku, Palantir, Robinhood, Roblox, Zoom, Block, Shopify and UiPath — though the lineup turns over heavily. Mid-2026 weights may differ materially; check ARK's daily-published holdings before sizing a position.

Trait	ARKK reality
Number of holdings	~30-40
Top 10 weight	Around 60% of the fund
Annual turnover	Roughly 70% per year
Sector tilt	Tech, biotech, fintech, crypto-adjacent
Distributions	Historically negligible

A real differentiator: ARK publishes its daily trades and open research notes, which is unusual for active managers. Whatever you think of the thesis, the transparency is genuine.

The tax picture — gains, not dividends

Unlike VOO or SCHD, ARKK is not a dividend story. Most years the distribution has been zero or trivial. The tax that actually bites is capital gains.

Capital gains — Section 112. US-listed ETFs do not get the Section 112A treatment Indian-listed equity enjoys:

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

The gain is computed in rupees, so a weaker rupee at sale amplifies your reported gain. Model with the US capital-gains calculator; full rules in how US stocks are taxed in India.

If a distribution does happen. US withholds 25% under DTAA with a W-8BEN, you declare the gross amount in India at slab, and you claim the 25% as foreign tax credit via Form 67 (Form 44 from TY 2026-27). Mechanics: dividend withholding and Form 67.

The $60,000 estate-tax trap

Directly-held ARKK is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there is no relief. ARKK is volatile enough that the position can swing across this threshold both ways, but the underlying risk applies whenever your aggregate US-situs holdings cross it. Full detail: the $60,000 estate-tax trap.

Alternatives — three honest routes to "innovation" exposure

If what you really want is exposure to innovation themes, ARKK is one of three routes, and they are not equivalent:

Route	Expense	What you get	Honest tradeoff
ARKK (active, US-listed)	0.75%	Cathie Wood's concentrated thematic bets	High cost, key-person risk, very high volatility
QQQ (passive, Nasdaq-100)	0.20%	100 largest non-financial Nasdaq names, megacap-tech heavy	Cheaper, much more diversified, far less thematic — but not "disruptive innovation" in the ARK sense
Individual disruptive names	$0 ongoing	Direct stocks: Tesla, Palantir, Coinbase, etc.	No active-management drag, but you do the picking — see our Tesla and Palantir guides

There is no clean Indian mutual-fund equivalent for ARKK's specific thesis — a few domestic innovation/tech MFs exist but they are India-focused or global-tech generalist, not ARK-style concentrated US disruption. See direct stocks vs US ETFs and best US ETFs for Indian investors; broader context in US ETFs for Indians.

Our take

Verdict: HOLD — ARKK is defensible only as a small satellite position if you specifically believe Cathie Wood's thesis. On cost and concentration grounds, it is hard to recommend as a default.

• The thesis bet is real. ARKK is not the S&P 500 in a costume. You are paying for a specific worldview — that genomics, AI, blockchain and fintech produce outsized winners over a decade, and that ARK's team can pick them. If you do not hold that view, do not own ARKK.
• Cost compounds against you. 0.75% is roughly 25x VOO and 3.75x QQQ. Over 20 years that gap, before any stock-picking edge, is a meaningful headwind.
• The 2020-22 round trip is the cautionary tale. ARKK roughly tripled in 2020, then drew down around 75% peak-to-trough through 2022 as rates rose and unprofitable growth names re-rated. It has partially recovered since, but the volatility profile is closer to a single high-beta stock than a diversified ETF. Position-size accordingly.
• Transparency is a real plus. ARK publishes daily trade notifications and open research notes. Among active managers, that is unusually honest, and worth crediting even if you disagree with the calls.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Concentration risk. Top 10 holdings are around 60% of the fund. A bad quarter in Tesla, Coinbase or any other oversized position drags the entire ETF.
• High turnover. Roughly 70% annual turnover means ARK is actively trading the portfolio — that has cost drag and tax-inefficiency implications inside the fund.
• Active-management cost. 0.75% is heavy. Over time, this has to be earned back through stock-picking alpha, and the historical record on that is contested.
• Redemption pressure during drawdowns. Thematic ETFs see heavy outflows in downturns, forcing selling at bad prices and compounding the drawdown for remaining holders.
• Key-person risk. ARKK is Cathie Wood as a brand. If she leaves, retires, or ARK's process changes, the entire reason to own ARKK shifts overnight.
• USD-INR currency. Returns are in USD but you spend rupees — see the rupee-dollar effect.
• US policy risk. Tax-treaty changes, dividend-withholding shifts, or LRS-rule tweaks can change the after-tax math without warning.

Two things people forget

• Schedule FA: disclose ARKK in Schedule FA of your ITR every year you hold it — even at a loss, even if down 70%. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper.
• Form 67 (Form 44 from TY 2026-27): if ARKK ever distributes anything, file the form to claim the 25% US withholding as foreign tax credit. Skip the form and you have effectively paid tax twice.

Bottom line

Buying ARKK from India is easy and legal. What needs thought is everything else: this is an actively-managed, concentrated, high-volatility thematic ETF at 0.75%, with the same $60k US estate trap and Section 112 capital-gains treatment. Defensible as a small satellite if you buy Cathie Wood's disruptive-innovation thesis; hard to defend as a core position on cost and concentration grounds. For accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.